Compare TRMK & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TRMK | HAE |
|---|---|---|
| Founded | 1889 | 1971 |
| Country | United States | United States |
| Employees | N/A | 3023 |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.8B |
| IPO Year | 1994 | 1996 |
| Metric | TRMK | HAE |
|---|---|---|
| Price | $44.40 | $59.78 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 9 |
| Target Price | $44.50 | ★ $84.13 |
| AVG Volume (30 Days) | 309.5K | ★ 610.0K |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.23% | N/A |
| EPS Growth | 1.93 | ★ 44.54 |
| EPS | ★ 3.70 | 2.46 |
| Revenue | N/A | ★ $910,373,000.00 |
| Revenue This Year | $9.82 | N/A |
| Revenue Next Year | $4.86 | $5.23 |
| P/E Ratio | ★ $12.12 | $24.14 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $33.09 | $47.32 |
| 52 Week High | $45.82 | $87.32 |
| Indicator | TRMK | HAE |
|---|---|---|
| Relative Strength Index (RSI) | 55.33 | 50.01 |
| Support Level | $43.39 | $48.47 |
| Resistance Level | $45.43 | $62.78 |
| Average True Range (ATR) | 0.86 | 1.93 |
| MACD | -0.01 | 0.26 |
| Stochastic Oscillator | 51.50 | 51.06 |
Trustmark Corp is a bank holding company. Through its subsidiaries, the company operates as a financial services organization providing banking and other financial solutions in Alabama, Florida, Mississippi, Tennessee, and Texas. Its principal products and services include Commercial Banking, Consumer Banking, Mortgage Banking, Insurance, Wealth Management and Trust Services, and others. The company is managed along two operating segments: General Banking and Wealth Management. The General Banking segment, which generates the majority of the revenue, provides all traditional banking products and services, including loan deposits, and also consists of internal operations.
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.